EXPERIMENTAL INDUCTION AND EVALUTION OF POLYCYSTIC OVARIAN DISEASE (PCOD) IN RODENT MODELS: MECHANISM, METHODS, AND PHARMACOLOGICAL INSIGHTS

Polycystic Ovarian Disease (PCOD), also widely known as Polycystic Ovary Syndrome is a complex endocrine and metabolic disorder affecting a significant proportion of women of childbearing age worldwide. Characterized by menstrual irregularities, hyperandrogenism, polycystic ovarian morphology, and metabolic abnormalities such as insulin resistance and dyslipidemia, PCOD presents a multifaceted clinical challenge. Understanding its pathophysiology is critical for developing effective therapeutic strategies. Rodent models, contain rats and mice, have emerged as indispensable tools for elucidating the underlying mechanisms of PCOD. These models replicate key features of the disorder, including hormonal imbalance, ovarian cyst formation, anovulation, and metabolic disturbances, under controlled experimental conditions. Several induction methods, including hormonal administration (androgens and Estrogen), pharmacological agents such as letrozole, and diet-induced approaches using high-fat or high-sugar diets, have been employed to create reliable PCOD models in rodents. Evaluation of these models involves comprehensive assessment of ovarian morphology, serum hormonal profiles, metabolic parameters, and molecular markers related to oxidative stress, inflammation, and apoptosis. Furthermore, rodent models serve as effective platforms to evaluate pharmacological interventions, ranging from conventional agents like metformin to herbal and novel bioactive compounds. By bridging preclinical findings with clinical relevance, these models provide valuable insights into disease mechanisms, potential therapeutic targets, and translational applications for human PCOD. This review consolidates current experimental strategies, evaluation techniques, and therapeutic insights, emphasizing the importance of rodent models as a cornerstone in PCOD research and highlighting their role in advancing our understanding and management of this prevalent disorder.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-15
DOI
https://doi.org/10.5281/zenodo.17615972
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EXPERIMENTAL INDUCTION AND EVALUTION OF POLYCYSTIC OVARIAN DISEASE (PCOD) IN RODENT MODELS: MECHANISM, METHODS, AND PHARMACOLOGICAL INSIGHTS

Zenodo (CERN European Organization for Nuclear Research)
Ovarian function and disorders
article

EXPERIMENTAL INDUCTION AND EVALUTION OF POLYCYSTIC OVARIAN DISEASE (PCOD) IN RODENT MODELS: MECHANISM, METHODS, AND PHARMACOLOGICAL INSIGHTS

article en

Abstract

Polycystic Ovarian Disease (PCOD), also widely known as Polycystic Ovary Syndrome is a complex endocrine and metabolic disorder affecting a significant proportion of women of childbearing age worldwide. Characterized by menstrual irregularities, hyperandrogenism, polycystic ovarian morphology, and metabolic abnormalities such as insulin resistance and dyslipidemia, PCOD presents a multifaceted clinical challenge. Understanding its pathophysiology is critical for developing effective therapeutic strategies. Rodent models, contain rats and mice, have emerged as indispensable tools for elucidating the underlying mechanisms of PCOD. These models replicate key features of the disorder, including hormonal imbalance, ovarian cyst formation, anovulation, and metabolic disturbances, under controlled experimental conditions. Several induction methods, including hormonal administration (androgens and Estrogen), pharmacological agents such as letrozole, and diet-induced approaches using high-fat or high-sugar diets, have been employed to create reliable PCOD models in rodents. Evaluation of these models involves comprehensive assessment of ovarian morphology, serum hormonal profiles, metabolic parameters, and molecular markers related to oxidative stress, inflammation, and apoptosis. Furthermore, rodent models serve as effective platforms to evaluate pharmacological interventions, ranging from conventional agents like metformin to herbal and novel bioactive compounds. By bridging preclinical findings with clinical relevance, these models provide valuable insights into disease mechanisms, potential therapeutic targets, and translational applications for human PCOD. This review consolidates current experimental strategies, evaluation techniques, and therapeutic insights, emphasizing the importance of rodent models as a cornerstone in PCOD research and highlighting their role in advancing our understanding and management of this prevalent disorder.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 34%
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.